Literature DB >> 210958

Differential expression of Rous Sarcoma virus-specific transformation parameters in enucleated cells.

H Beug, M Claviez, B M Jockusch, T Graf.   

Abstract

Chicken embryo fibroblasts transformed with the Ta and ts68 mutants of Rous Sarcoma virus (RSV) were enucleated and studied for their capacity to express reversibly the transformed phenotype in response to temperature changes. After shift to the permissive temperature (35 degrees C), the cytoplasts acquired a transformed morphology and displayed characteristic ruffles and microvilli at their surface. As detected by immunofluorescence, they also lost their actin filament cables and exhibited characteristic changes in the pattern of cell surface structures containing LETS protein. Expression of all these transformation parameters was reversible after shiftback to the nonpermissive temperature (41 degrees C). These results indicate that a whole set of changes characteristic for the transformed phenotype can be expressed independently of the cell nucleus. In contrast, ts mutant-infected cytoplasts were no longer able to respond to temperature shifts with changes in their hexose transport rate. Cytoplasts prepared from cells grown at 41 degrees C retained their low rate of hexose uptake after shift to 35 degrees C, whereas cytoplasts from cells grown at 35 degrees C exhibited a high rate of hexose transport even after 10 hr of shift to 41 degrees C. These results are in accordance with the hypothesis that the product of the src gene of RSV represents a multifunctional protein which acts independently on nuclear and extranuclear sites.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210958     DOI: 10.1016/0092-8674(78)90340-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  21 in total

1.  The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via phosphatidylinositol 3-kinase.

Authors:  V J Fincham; V G Brunton; M C Frame
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Intracellular monosaccharide and amino acid concentrations and activities and the mechanisms of insulin action.

Authors:  S B Horowitz; T W Pearson
Journal:  Mol Cell Biol       Date:  1981-09       Impact factor: 4.272

Review 3.  Contributions of microbiology to eucaryotic cell biology: new directions for microbiology.

Authors:  R Dulbecco
Journal:  Microbiol Rev       Date:  1979-12

4.  The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility.

Authors:  V J Fincham; M C Frame
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

5.  Phosphorylation of talin at tyrosine in Rous sarcoma virus-transformed cells.

Authors:  J E DeClue; G S Martin
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

6.  Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenes.

Authors:  D Shalloway; P J Johnson; E O Freed; D Coulter; W A Flood
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

7.  Biological properties of "partial" transformation mutants of Rous sarcoma virus and characterization of their pp60src kinase.

Authors:  D D Anderson; R P Beckmann; E H Harms; K Nakamura; M J Weber
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

8.  Separation of v-Src-induced mitogenesis and morphological transformation by inhibition of AP-1.

Authors:  M C Frame; K Simpson; V J Fincham; D H Crouch
Journal:  Mol Biol Cell       Date:  1994-11       Impact factor: 4.138

9.  Avian erythroblastosis virus produces two mRNA's.

Authors:  S M Anderson; W S Hayward; B G Neel; H Hanafusa
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

10.  The response of chicken embryo dermal fibroblasts to cytochalasin B is altered by Rous sarcoma virus-induced cell transformation.

Authors:  A S Menko; J Croop; Y Toyama; H Holtzer; D Boettiger
Journal:  Mol Cell Biol       Date:  1982-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.